Recordati has a total of 914 patents globally, out of which 518 have been granted. Of these 914 patents, more than 36% patents are active. The USA is where Recordati has filed the maximum number of patents, followed by European Countries. Parallelly, the USA seems to be the main focused R&D centre of Recordati.
Recordati was founded in the year 1926. Company is an international pharmaceutical group. As of March 2023, Recordati has a market cap of $8.74 Billion.
Do read about some of the most popular patents of Recordati which have been covered by us in this article and also you can find Recordati patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Recordati patent portfolio.
How many patents does Recordati have?
Recordati has a total of 914 patents globally. These patents belong to 166 unique patent families. Out of 914 patents, 334 patents are active.
How Many Patents did Recordati File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Recordati Applications Filed | Recordati Patents Granted |
| 2022 | 7 | 4 |
| 2021 | 7 | 24 |
| 2020 | 5 | 33 |
| 2019 | 5 | 16 |
| 2018 | 4 | 19 |
| 2017 | 12 | 25 |
| 2016 | 22 | 23 |
| 2015 | 32 | 38 |
| 2014 | 4 | 40 |
| 2013 | 34 | 21 |
| 2012 | 22 | 36 |
| 2011 | 37 | 28 |
Which Recordati Drug Patents are Expiring in the Next 10 Years?
The patent no. US10709691B2 which is expiring in Oct, 2035, describing dosage forms for treating Cushing’s disease or Cushing’s syndrome contain the drug 4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile or its pharmaceutically acceptable salt.
Given below is the list of few drugs patented by Recordati accompanied by a patent relevant to the drug which will be available for generic drug manufacturing and usage within the next/upcoming 10 years for treatment of various diseases and disorders.
| Drug Name | Patent Number | Patent Title | Patent Expiration |
| Isturisa | US10709691B2 | Pharmaceutical Dosage Forms | Oct, 2035 |
| Signifor Lar Kit | US7759308B2 | Microparticles Comprising Somat… | Oct, 2026 |
| Signifor | US7473761B2 | Somatostatin Analogues | Dec, 2026 |
Interested in knowing about Recordati’s Drug Patents Expiring in the next 10 years?
How many Recordati patents are Alive/Dead?
How Many Patents did Recordati File in Different Countries?
Countries in which Recordati Filed Patents
| Country | Patents |
| United States Of America | 73 |
| Europe | 55 |
| Germany | 48 |
| Australia | 38 |
| Spain | 35 |
| China | 34 |
| Denmark | 31 |
| Canada | 30 |
| Norway | 29 |
| Poland | 26 |
| Brazil | 25 |
| Israel | 24 |
| Hong Kong (S.A.R.) | 22 |
| New Zealand | 21 |
| Taiwan | 21 |
| Korea (South) | 20 |
| Portugal | 20 |
| South Africa | 19 |
| Singapore | 19 |
| Japan | 18 |
| Mexico | 17 |
| Indonesia | 16 |
| India | 14 |
| Austria | 14 |
| Viet Nam | 14 |
| Eurasia | 14 |
| Slovenia | 14 |
| Malta | 14 |
| Croatia | 10 |
| Ukraine | 10 |
Where are Research Centres of Recordati Patents Located?
10 Best Recordati Patents
US7612182B2 is the most popular patent in the Recordati portfolio. It has received 75 citations so far from companies like Ethicon Endo-Surgery, Kodiak Sciences, and Novo Nordisk.
Below is the list of 10 most cited patents of Recordati:
| Publication Number | Citation Count |
| US7612182B2 | 75 |
| US20040198789A1 | 71 |
| US7955597B2 | 62 |
| US7473761B2 | 60 |
| US7071197B2 | 51 |
| US7833786B2 | 46 |
| US8415337B1 | 41 |
| WO2003014084A1 | 36 |
| US20030069285A1 | 34 |
| US20030180355A1 | 31 |